MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,566,000 | +15.4% | 55,537 | +105.9% | 0.00% | 0.0% |
| Q4 2021 | $3,957,000 | -54.9% | 26,976 | -45.6% | 0.00% | -60.0% |
| Q3 2021 | $8,772,000 | +90.4% | 49,582 | +73.9% | 0.01% | +66.7% |
| Q2 2021 | $4,607,000 | -3.4% | 28,519 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $4,768,000 | -41.6% | 27,837 | -25.2% | 0.00% | -40.0% |
| Q4 2020 | $8,169,000 | +79.2% | 37,191 | +35.5% | 0.01% | +66.7% |
| Q3 2020 | $4,559,000 | +167.7% | 27,455 | +84.1% | 0.00% | +200.0% |
| Q2 2020 | $1,703,000 | +124.1% | 14,917 | +50.9% | 0.00% | 0.0% |
| Q1 2020 | $760,000 | -59.6% | 9,888 | -32.3% | 0.00% | 0.0% |
| Q4 2019 | $1,882,000 | +53.9% | 14,607 | -6.9% | 0.00% | 0.0% |
| Q3 2019 | $1,223,000 | -33.1% | 15,692 | -11.6% | 0.00% | -50.0% |
| Q2 2019 | $1,828,000 | +87.3% | 17,749 | +33.3% | 0.00% | +100.0% |
| Q1 2019 | $976,000 | +5.6% | 13,314 | -32.2% | 0.00% | 0.0% |
| Q3 2018 | $924,000 | -40.5% | 19,623 | -37.7% | 0.00% | 0.0% |
| Q2 2018 | $1,553,000 | – | 31,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |